Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer
TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.17, no.2, pp.123-127, 2020 (ESCI, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 17 Issue: 2
- Publication Date: 2020
- Doi Number: 10.4274/tjod.galenos.2020.90699
- Journal Name: TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.123-127
- Open Archive Collection: AVESIS Open Access Collection
- Kütahya Health Sciences University Affiliated: Yes
Abstract
Objective: To evaluate the efficacy of bevacizumab a monoclonal, antivascular endothelial growth factor antibody in combination with cytotoxic chemotherapy in Turkish patients with recurrent and metastatic cervical cancer.